111

IMMUNEONCO BIOPHARMACEUTICALS (SHAN

No trades
See on Supercharts
Market capitalization
‪5.65 B‬HKD
−1.12HKD
‪−419.30 M‬HKD
‪426.53 K‬HKD
‪73.72 M‬
Beta (1Y)
0.42

About IMMUNEONCO BIOPHARMACEUTICALS (SHAN

CEO
Wen Zhi Tian
Headquarters
Zhangjiang Science City
Employees (FY)
145
Founded
2015
ISIN
CNE100006624
FIGI
BBG01J20MWK7
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. It focus on the adaptive immune system and are often confronted with limited clinical benefits due to low response rates and inevitable drug resistance and/or relapse in many cancer indications. The company was founded by Dr. Tian Wenzhi in June 2015 and is headquartered in Zhangjiang Science City, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1541 is 15.10 HKD — it has increased by 1.07% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange IMMUNEONCO BIOPHARMACEUTICALS (SHAN stocks are traded under the ticker 1541.
1541 stock is 6.56% volatile and has beta coefficient of 0.42. Check out the list of the most volatile stocks — is IMMUNEONCO BIOPHARMACEUTICALS (SHAN there?
Yes, you can track IMMUNEONCO BIOPHARMACEUTICALS (SHAN financials in yearly and quarterly reports right on TradingView.
1541 stock has risen by 11.19% compared to the previous week, the month change is a 1.31% fall, over the last year IMMUNEONCO BIOPHARMACEUTICALS (SHAN has showed a 28.77% decrease.
1541 net income for the last quarter is ‪−225.39 M‬ HKD, while the quarter before that showed ‪−193.20 M‬ HKD of net income which accounts for −16.66% change. Track more IMMUNEONCO BIOPHARMACEUTICALS (SHAN financial stats to get the full picture.
No, 1541 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1541 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUNEONCO BIOPHARMACEUTICALS (SHAN stock right from TradingView charts — choose your broker and connect to your account.
1541 reached its all-time high on Oct 3, 2023 with the price of 32.16 HKD, and its all-time low was 13.58 HKD and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has 145.00 employees. See our rating of the largest employees — is IMMUNEONCO BIOPHARMACEUTICALS (SHAN on this list?
We've gathered analysts' opinions on IMMUNEONCO BIOPHARMACEUTICALS (SHAN future price: according to them, 1541 price has a max estimate of 21.50 HKD and a min estimate of 21.50 HKD. Read a more detailed IMMUNEONCO BIOPHARMACEUTICALS (SHAN forecast: see what analysts think of IMMUNEONCO BIOPHARMACEUTICALS (SHAN and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMMUNEONCO BIOPHARMACEUTICALS (SHAN EBITDA is ‪−385.46 M‬ HKD, and current EBITDA margin is ‪−90.52 K‬%. See more stats in IMMUNEONCO BIOPHARMACEUTICALS (SHAN financial statements.